-
2021-04-7
727aa9649c01ee478dbdb18142da20740334eaf0
37
AstraZeneca
37
/wiki/oxford-astrazeneca%20covid-19%20vaccine
COVID-19 pandemic
1
/wiki/covid-19%20pandemic
European Medicines Agency
2
/wiki/european%20medicines%20agency
blood clot
14
/wiki/blood%20clot
AstraZeneca
COVID-19 pandemic
European Medicines Agency
blood clot
COVID-19 pandemic
2021-04-9
a57320cf7dab49a0bb726ab39d9f5d9dec10e2a5
/feed/2021/04/9/greece-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-30-years-old-following-reports-of-possible-lin
Greece restricts the use of the Oxford–AstraZeneca vaccine to people over 30 years old following reports of possible link to rare blood clotting cases.
1618016743
2021-04-9
2ee30cd9c81d4ca2905629cf2f5a9e5aa5696a58
22
AstraZeneca
COVID-19 pandemic
blood clot
3
/feed/2021/04/9/greece-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-30-years-old-following-reports-of-a-possible-l
Greece restricts the use of the Oxford–AstraZeneca vaccine to people over 30 years old following reports of a possible link with rare blood clotting cases.
2021-04-8
1ef3ab42e3d937d3ec002d56d9da9c5615443e40
/feed/2021/04/8/the-netherlands-officially-suspends-the-use-of-the-oxford-astrazeneca-vaccine-by-people-under-60-years-old-due-to-concer
The Netherlands officially suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old due to concerns over reports of severe blood clotting.
1711592249
2021-04-8
20521abbb8012423d01a1b2be356b589673b3a10
/feed/2021/04/8/the-food-and-drug-administration-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-60-years-old-followi
The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following reports of a possible link with rare cases of blood clots.
1617987953
2021-04-8
47fd494090a7cc3781a16f72f0194b8d0f781d21
/feed/2021/04/8/the-netherlands-officially-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-60-years-old-due-to-concer
The Netherlands officially suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old due to concerns over reports of severe blood clotting.
1617987952
2021-04-8
d68626981e8a48fd68bdc067283698e8a8567331
/feed/2021/04/8/the-food-and-drug-administration-suspends-the-use-of-the-oxford-astrazeneca-vaccine-for-those-aged-under-60-years-old-in
The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine for those aged under 60 years old in the Philippines following reports of possible link with rare cases of blood clots.
1617927249
2021-04-8
0416dbddae6ffd2aa64d4b49065e569fbccc0996
/feed/2021/04/8/the-netherlands-officially-halts-the-use-of-the-oxford-astrazeneca-vaccine-for-those-aged-under-60-years-old-due-to-conc
The Netherlands officially halts the use of the Oxford–AstraZeneca vaccine for those aged under 60 years old due to concern over rare severe blood clotting.
1617927245
2021-04-8
af3a052288b279ec04646375dac4c18d1b9f2265
23
AstraZeneca
COVID-19 pandemic
blood clot
3
/feed/2021/04/8/the-food-and-drug-administration-suspends-the-use-of-the-oxford-astrazeneca-vaccine-by-people-under-60-years-old-followi
The Food and Drug Administration suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following reports of a possible link with cases of blood clots.
2021-04-7
45ee6be5348247cec19d4f9ff2d955ee92aa0036
/feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-by-people-under-60-years-old-following-a-report-of-a-possible
Estonia suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following a report of a possible link with cases of blood clotting.
1711592232
2021-04-7
dd86b27e44dedfe2ca9f290b6d349f3765408b97
/feed/2021/04/7/the-ministry-of-health-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-60-years-old-following-a-repor
The Ministry of Health restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting.
1711592230
2021-04-7
c999b79831e13c0f740e79876ddfbe0820b206b7
/feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-60-years-old-following-a-report-of-a-possible
Estonia suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following a report of a possible link with cases of blood clotting.
1617987946
2021-04-7
68435713914e84303dcd86d56e76e393717f8d1a
/feed/2021/04/7/the-ministry-of-health-temporarily-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-60-years-old-follo
The Ministry of Health temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting.
1617858354
2021-04-7
31c5c63863486c5335de04767d7588ab718d3c0d
/feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-60-years-old-following-report-of-possible-link
Estonia suspends the use of the Oxford–AstraZeneca vaccine to people over 60 years old following report of possible link with the blood clotting cases.
1617843950
2021-04-7
823afcc1d941c533623cd57d2b5417f7240dc24b
26
AstraZeneca
COVID-19 pandemic
European Medicines Agency
blood clot
4
/feed/2021/04/7/belgium-temporarily-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-55-years-old-following-a-report-f
Belgium temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 55 years old following a report from the European Medicines Agency that there is a "possible link" between the vaccine and very rare blood clotting cases.
2021-04-7
040feae70bb3da0f9cf215ffda940ce873abf27a
32
AstraZeneca
COVID-19 pandemic
European Medicines Agency
3
/feed/2021/04/7/castile-and-leon-suspends-the-use-of-the-oxford-astrazeneca-covid-19-vaccine-until-the-european-medicines-agency-s-secur
Castile and León suspends the use of the Oxford–AstraZeneca COVID-19 vaccine until the European Medicines Agency's security report is published.
2021-03-30
4030b33e54e9fac993aacdb29f79491a5bd61895
/feed/2021/03/30/german-health-authorities-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-the-age-of-60-after-new-dat
German health authorities suspends the use of the Oxford–AstraZeneca vaccine in people under the age of 60 after new data showing a rise in unusual blood clots in the head was released.
1617246348
2021-03-30
5717a991d459cacde0325955206d8d48ca701bc2
/feed/2021/03/30/germany-suspends-the-use-of-the-astrazeneca-vaccine-in-people-under-the-age-of-60-after-new-data-showing-a-rise-in-unusu
Germany suspends the use of the AstraZeneca vaccine in people under the age of 60 after new data showing a rise in unusual blood clots in the head was released, of which 9 people had died.
1617138412
2021-03-30
c78f3b62e412b11096c3db6608ba7097e55897ce
16
AstraZeneca
COVID-19 pandemic
blood clot
3
/feed/2021/03/30/german-health-authorities-suspend-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-the-age-of-60-after-new-data
German health authorities suspend the use of the Oxford–AstraZeneca vaccine in people under the age of 60 after new data showing a rise in unusual blood clots in the head was released.
2021-03-19
ddfdddb6bb45b8c4fed5ec69216be7ea58d14e99
/feed/2021/03/19/germany-resumes-the-use-of-the-oxford-astrazeneca-vaccine-after-the-european-medicines-agency-declares-it-to-be-safe-and
Germany resumes the use of the Oxford-AstraZeneca vaccine after the European Medicines Agency declares it to be safe and is not associated with an increased risk of blood clots.
1616199433
2021-03-19
46bad07e595c81c8de7b9017651125cdd9f4e24c
24
AstraZeneca
COVID-19 pandemic
European Medicines Agency
blood clot
4
/feed/2021/03/19/germany-resumes-its-use-of-the-oxford-astrazeneca-vaccine-after-the-european-medicines-agency-declares-it-to-be-safe-and
Germany resumes its use of the Oxford-AstraZeneca vaccine after the European Medicines Agency declares it to be safe and not associated with an increased risk of blood clots.
2021-03-19
87a6ce5ccb2dc4e2764ce3295ba86bf6b3e1e73f
/feed/2021/03/19/finland-suspends-the-use-of-the-oxford-astrazeneca-vaccine-after-it-reporting-two-cases-of-unusual-blood-clotting-in-the
Finland suspends the use of the Oxford-AstraZeneca vaccine after it reporting two cases of unusual blood clotting in the brain.
1616199431
2021-03-19
a11899e40adc7a818916f04e7fe97f2d3ca49e81
20
AstraZeneca
COVID-19 pandemic
blood clot
3
/feed/2021/03/19/finland-suspends-the-use-of-the-oxford-astrazeneca-vaccine-after-reporting-two-cases-of-unusual-blood-clotting-in-the-br
Finland suspends the use of the Oxford-AstraZeneca vaccine after reporting two cases of unusual blood clotting in the brain in vaccinated people.
2021-03-19
6638a677a13c18ea46a9735e77e52633ca36c8d7
14
AstraZeneca
COVID-19 pandemic
blood clot
3
/feed/2021/03/19/the-french-national-authority-for-health-limits-the-use-of-the-oxford-astrazeneca-vaccine-to-those-aged-over-55-years-ol
The French National Authority for Health limits the use of the Oxford-AstraZeneca vaccine to those aged over 55 years old after it was discovered that three patients who suffered blood clots are younger than 55 years old.
2021-03-14
abf45e3eb0376d063099a065fd662f5aac49c177
/feed/2021/03/14/piedmont-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-after-a-teacher-in-the-town-of-biella-reportedly
Piedmont temporarily suspends the use of the Oxford–AstraZeneca vaccine after a teacher in the town of Biella reportedly died after receiving the vaccine.
1711591903
2021-03-14
b0ce8bd5304031394535a28adba67d327942fa40
/feed/2021/03/14/the-netherlands-suspends-the-use-of-the-oxford-astrazeneca-vaccine-until-march-29-following-reports-of-denmark-and-norwa
The Netherlands suspends the use of the Oxford–AstraZeneca vaccine until March 29 following reports of Denmark and Norway regarding possible serious side effects.
1711591901
2021-03-14
d6e4a20d99c066e401566a59e9120e281c8b3270
/feed/2021/03/14/piedmont-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-following-reports-about-the-death-of-a-vaccinate
Piedmont temporarily suspends the use of the Oxford–AstraZeneca vaccine following reports about the death of a vaccinated teacher in the town of Biella.
1615777585
2021-03-14
274e695a48e7105b2a1b393455872a1b85a0f995
/feed/2021/03/14/italy-s-piedmont-region-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-following-reports-about-the-death
Italy's Piedmont region temporarily suspends the use of the Oxford–AstraZeneca vaccine following reports about the death of a vaccinated teacher in the town of Biella.
1615767280
2021-03-14
9025978b7b1380580398b563ec69d04b13a2b28d
/feed/2021/03/14/the-government-of-ireland-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-following-report-from-the-norwe
The Government of Ireland temporarily suspends the use of the Oxford–AstraZeneca vaccine following report from the Norwegian Medicines Agency over serious blood clots in four people that received the vaccine, which one of them had died.
1615755995
2021-03-14
0a291c0d0d04a7ff49e4c56d33cb490c77d3edfa
8
AstraZeneca
COVID-19 pandemic
blood clot
3
/feed/2021/03/14/the-government-of-ireland-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-following-reports-from-the-norw
The Government of Ireland temporarily suspends the use of the Oxford–AstraZeneca vaccine following reports from the Norwegian Medicines Agency regarding serious blood clots developing in four people who received the vaccine, one of whom later died.
2021-01-29
b5441d021954f9a17a21839f541cd2ca7feef8cd
34
AstraZeneca
COVID-19 pandemic
European Medicines Agency
3
/feed/2021/01/29/the-european-medicines-agency-approves-the-oxford-astrazeneca-vaccine-for-use-within-the-eu-and-recommends-that-the-euro
The European Medicines Agency approves the Oxford-AstraZeneca Vaccine for use within the EU and recommends that the European Commission grant it 'limited marketing authorization' within the union.
/feed/2021/04/7/the-european-medicines-agency-announces-that-blood-clotting-should-be-listed-as-a-very-rare-side-effect-of-the-oxford
DW
7
7112b3921577589ce2eae607cba2b56c7e023c3e
4
https://www.dw.com/en/astrazeneca-ema-says-blood-clots-very-rare-side-effect/a-57118315
2021
The European Medicines Agency announces that blood clotting should be listed as a "very rare" side effect of the Oxford–AstraZeneca vaccine. It also insists that benefits of using the vaccine continue to outweigh the risks.